Cargando…
Poly(2-methoxyethyl acrylate) (PMEA) improves the thromboresistance of FRED flow diverters: a thrombogenic evaluation of flow diverters with human blood under flow conditions
BACKGROUND: Surface modification of flow-diverting stents has been explored to reduce thrombus-related complications that may arise under clinical use. This study investigated the thromboresistant properties of the flow redirection endoluminal device (FRED) X, a flow diverter treated with a copolyme...
Autores principales: | Yoshizawa, Keiko, Kobayashi, Hirohisa, Kaneki, Atsushi, Takenouchi, Mika, Belletto, John, Baldwin, Aaron, Anzai, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511968/ https://www.ncbi.nlm.nih.gov/pubmed/36180206 http://dx.doi.org/10.1136/jnis-2022-019248 |
Ejemplares similares
-
Efficacy and safety of the dual-layer flow-diverting stent (FRED) for the treatment of intracranial aneurysms
por: Guimaraens, Leopoldo, et al.
Publicado: (2020) -
Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model
por: Girdhar, Gaurav, et al.
Publicado: (2018) -
Comparison of the Thrombogenicity of a Bare and Antithrombogenic Coated Flow Diverter in an In Vitro Flow Model
por: Lenz-Habijan, T., et al.
Publicado: (2019) -
Initial experience with implantation of novel dual layer flow-diverter device FRED
por: Poncyljusz, Wojciech, et al.
Publicado: (2013) -
Coating (Coating to Optimize Aneurysm Treatment in the New Flow Diverter Generation) study. The first randomized controlled trial evaluating a coated flow diverter (p64 MW HPC): study design
por: Pierot, Laurent, et al.
Publicado: (2023)